MARÍA JESÚS
TUÑÓN GONZÁLEZ
Investigadora en el període 2000-2023
Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (31)
2023
-
Hepatocellular carcinoma cells loss lenvatinib efficacy in vitro through autophagy and hypoxia response-derived neuropilin-1 degradation
Acta Pharmacologica Sinica, Vol. 44, Núm. 5, pp. 1066-1082
-
Neuropilins as potential biomarkers in hepatocel-lular carcinoma: a systematic review of basic and clinical implications
Clinical and Molecular Hepatology, Vol. 29, Núm. 2, pp. 293-319
2022
-
Beneficial effects of melatonin on liver fibrosis: A systematic review of current biological evidence
Journal of Cellular Physiology, Vol. 237, Núm. 7, pp. 2740-2757
-
Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies
Cancers, Vol. 14, Núm. 14
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Melatonin as an antitumor agent against liver cancer: An updated systematic review
Antioxidants, Vol. 10, Núm. 1, pp. 1-27
2020
-
Melatonin modulates mitophagy, innate immunity and circadian clocks in a model of viral-induced fulminant hepatic failure
Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 13, pp. 7625-7636
2019
-
Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: A systematic review
Nutrients, Vol. 11, Núm. 12
2018
-
Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells
Frontiers in Pharmacology, Vol. 9, Núm. MAY
-
Melatonin modulates dysregulated circadian clocks in mice with diethylnitrosamine-induced hepatocellular carcinoma
Journal of Pineal Research, Vol. 65, Núm. 3
2017
-
Effects of oral glutamine on inflammatory and autophagy responses in cancer patients treated with abdominal radiotherapy: A pilot randomized trial
International Journal of Medical Sciences, Vol. 14, Núm. 11, pp. 1065-1071
-
Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells
BioFactors, Vol. 43, Núm. 2, pp. 272-282
-
Melatonin prevents deregulation of the sphingosine kinase/sphingosine 1-phosphate signaling pathway in a mouse model of diethylnitrosamine-induced hepatocellular carcinoma
Journal of Pineal Research, Vol. 62, Núm. 1
-
Protective effect of protocatechuic acid on TNBS-induced colitis in mice is associated with modulation of the SphK/S1P signaling pathway
Nutrients, Vol. 9, Núm. 3
-
Sphingosine 1-phosphate signaling as a target in hepatic fibrosis therapy
Frontiers in Pharmacology, Vol. 8, Núm. AUG
2016
-
Melatonin inhibits the sphingosine kinase 1/sphingosine-1-phosphate signaling pathway in rabbits with fulminant hepatitis of viral origin
Journal of Pineal Research, pp. 168-176
2015
-
Melatonin inhibits autophagy and endoplasmic reticulum stress in mice with carbon tetrachloride-induced fibrosis
Journal of Pineal Research, Vol. 59, Núm. 2, pp. 151-162
-
Melatonin limits the expression of profibrogenic genes and ameliorates the progression of hepatic fibrosis in mice
Translational Research, Vol. 165, Núm. 2, pp. 346-357
-
Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase
Journal of Pineal Research, Vol. 59, Núm. 3, pp. 391-404